Exos Acquires Infinite Athlete and Its Subsidiary Biocore to Shape the Future of Human Performance

(October 30, 2025) - Exos, the global leader in human performance, today announced the acquisition of sports technology company, Infinite Athlete and its subsidiary Biocore. The company and acquisition is backed by private equity firms BDT & MSD Partners and Madrone Capital Partners.

Infinite Athlete and Biocore will operate under the Exos brand, guided by a high-caliber leadership team with deep expertise in sports, technology, health and safety, and performance innovation. The transaction unites Exos founder Mark Verstegen, Infinite Athlete founder Charlie Ebersol, and Biocore founder Dr. Jeff Crandall, each bringing decades of experience and vision to the future of human performance, with Dan Burns leading the organization as chief executive officer.

"Exos has always been about unlocking human potential, working across athletes and performers of all types,” said Dan Burns, chief executive officer, Exos. “The data we have from that work, along with the human performance and coaching expertise to take action on it, presents a powerful opportunity. By fusing this with the technology, data science and biomechanical engineering of Infinite Athlete and Biocore, we will focus on turning data into personalized insights that drive peak performance and sustainable competitive advantage across sport, work and life."

“When we acquired Biocore in 2023, creating Infinite Athlete, we began building the most advanced AI-driven, data science and research framework for elite performance,” said Charlie Ebersol, founder, Infinite Athlete. “Having accomplished that with some of our biggest partners, we are ready to scale our technology and biomechanics across Exos’ vast client base, as we join their portfolio of companies.” Ebersol continued, “This acquisition is the next step in expanding our footprint with a company that shares our same commitment to advance the field of human performance.”

This transformative acquisition marks the next chapter for Exos as it blends human expertise with AI and data-driven insights to revolutionize human performance. The company will focus on expanding its tech-forward products and services across professional sports, collegiate and youth athletics, corporate workplace solutions, healthcare, and the U.S. military, redefining how performance is measured, improved, and sustained.

“Exos has always believed that past success fuels future innovation,” said Mark Verstegen, founder and president, Exos, “Dr. Jeff Crandall and I have a shared commitment to advancing athlete health, safety, and performance. With Biocore’s pioneering work in biomechanics and Infinite Athlete’s cutting-edge technology, we’re accelerating and automating the Exos engine, bringing science, data, and coaching together to create smarter, safer, and more personalized performance solutions for the next generation of athletes, teams, and organizations.”

“Mark Verstegen and I have been working on complementary tracks for nearly 20 years —  innovating health and safety protocols and creating the gold standard for performance,” said Dr. Jeff Crandall, CEO and founder, Biocore. “This partnership will allow us to continue serving our respected clients with leading biomechanical engineering, testing and data science analytics, while setting us up to collaborate on opportunities that will leverage the expertise of each company, to create the future of human performance.”